Mastektomi \u0259sas\u0259n s\u00fcd v\u0259zi toxumas\u0131n\u0131n tamam\u0131n\u0131n c\u0259rrahi \u00fcsulla \u00e7\u0131xar\u0131lmas\u0131 dem\u0259kdir. Ba\u015fqa s\u00f6zl\u0259, s\u00fcd v\u0259zi daxilind\u0259ki x\u0259r\u00e7\u0259ngli v\u0259 ya x\u0259r\u00e7\u0259ng riski da\u015f\u0131yan toxuman\u0131 aradan qald\u0131rmaq m\u0259qs\u0259dil\u0259 edil\u0259n bir \u0259m\u0259liyyatt\u0131r. Bu g\u00fcn mastektomi yaln\u0131z x\u0259r\u00e7\u0259ngli toxuman\u0131n t\u0259mizl\u0259nm\u0259si \u00fc\u00e7\u00fcn deyil, h\u0259m d\u0259 x\u0259r\u00e7\u0259ng riskini \u0259h\u0259miyy\u0259tli d\u0259r\u0259c\u0259d\u0259 azaltmaq \u00fc\u00e7\u00fcn profilaktik m\u0259qs\u0259dl\u0259 t\u0259tbiq oluna bil\u0259r. Prosedur \u00fcmumi anesteziya alt\u0131nda h\u0259yata ke\u00e7irilir v\u0259 c\u0259rrah\u0131n m\u0259qs\u0259di s\u00fcd v\u0259zi toxumas\u0131n\u0131 tamamil\u0259 t\u0259mizl\u0259y\u0259rk\u0259n x\u0259st\u0259nin h\u0259yat komfortunu m\u00fcmk\u00fcn q\u0259d\u0259r qorumaqd\u0131r. T\u0259kmill\u0259\u015f\u0259n c\u0259rrahi texnikalar say\u0259sind\u0259 art\u0131q d\u00f6\u015f \u0259z\u0259l\u0259l\u0259rinin ham\u0131s\u0131 g\u00f6t\u00fcr\u00fclm\u00fcr, yaln\u0131z z\u0259ruri toxuma m\u00fcdaxil\u0259 edilir v\u0259 bel\u0259likl\u0259 x\u0259st\u0259l\u0259r \u0259vv\u0259lkind\u0259n daha s\u00fcr\u0259tl\u0259 sa\u011fala bil\u0259r, ist\u0259s\u0259l\u0259r eyni seansda ya da sonrak\u0131 m\u0259rh\u0259l\u0259d\u0259 rekonstruksiya (yenid\u0259n d\u00f6\u015f formala\u015fd\u0131rma) variantlar\u0131ndan yararlana bil\u0259rl\u0259r.<\/p>\n
| T\u0259tbiq S\u0259b\u0259bl\u0259ri<\/td>\n | – S\u00fcd v\u0259zi x\u0259r\u00e7\u0259ngi diaqnozu \n– S\u00fcd v\u0259zi x\u0259r\u00e7\u0259ngin\u0259 y\u00fcks\u0259k genetik meyllik (BRCA1\/BRCA2 mutasiyas\u0131) \n– Geni\u015f yay\u0131lm\u0131\u015f duktal karsinoma in situ (DCIS) \n– Radioterapiya \u00fc\u00e7\u00fcn uy\u011fun olmayan hallar<\/td>\n<\/tr>\n |
| \u018fm\u0259liyyat G\u00f6st\u0259ri\u015fl\u0259ri<\/td>\n | – Erk\u0259n m\u0259rh\u0259l\u0259 s\u00fcd v\u0259zi x\u0259r\u00e7\u0259ngi (b\u0259zi x\u0259st\u0259l\u0259rd\u0259 \u00fcst\u00fcnl\u00fck veril\u0259 bil\u0259r) \n– Lokal inki\u015faf etmi\u015f m\u0259rh\u0259l\u0259 s\u00fcd v\u0259zi x\u0259r\u00e7\u0259ngi \n– Profilaktik m\u0259qs\u0259dli (y\u00fcks\u0259k riskli \u015f\u0259xsl\u0259rd\u0259) \n– T\u0259krarlanan s\u00fcd v\u0259zi x\u0259r\u00e7\u0259ngi<\/td>\n<\/tr>\n |
| Prosedur N\u00f6vl\u0259ri<\/td>\n | – Total mastektomi (s\u00fcd v\u0259zi toxumas\u0131n\u0131n tam \u00e7\u0131xar\u0131lmas\u0131) \n– D\u0259ri qoruyucu mastektomi \n– S\u00fcd v\u0259zi ucu qoruyucu mastektomi \n– Radikal mastektomi (nadir hallarda, geni\u015f yay\u0131lma zaman\u0131) \n– Profilaktik mastektomi<\/td>\n<\/tr>\n |
| \u018fm\u0259liyyatdan \u00d6nc\u0259 Qiym\u0259tl\u0259ndirm\u0259<\/td>\n | – S\u00fcd v\u0259zi g\u00f6r\u00fcnt\u00fcl\u0259nm\u0259si (mamografiya, MR) \n– Biopsiya n\u0259tic\u0259l\u0259rinin qiym\u0259tl\u0259ndirilm\u0259si \n– \u00dcmumi anesteziyaya uy\u011funlu\u011fun qiym\u0259tl\u0259ndirilm\u0259si \n– X\u0259st\u0259nin m\u0259lumatland\u0131r\u0131lmas\u0131 v\u0259 raz\u0131l\u0131q al\u0131nmas\u0131<\/td>\n<\/tr>\n |
| M\u00fcalic\u0259 Sonras\u0131 Proses<\/td>\n | – \u018fm\u0259liyyatdan sonra drenl\u0259rin izl\u0259nm\u0259si \n– A\u011fr\u0131 v\u0259 infeksiya n\u0259zar\u0259ti \n– Fiziki terapiya (qol h\u0259r\u0259k\u0259tl\u0259ri \u00fc\u00e7\u00fcn) \n– Psixoloji d\u0259st\u0259k \n– Laz\u0131m g\u0259l\u0259rs\u0259 rekonstruksiya (s\u00fcd v\u0259zi b\u0259rpas\u0131) planla\u015fd\u0131r\u0131lmas\u0131<\/td>\n<\/tr>\n |
| M\u00fcmk\u00fcn Komplikasiyalar<\/td>\n | – \u0130nfeksiya \n– Seroma (maye y\u0131\u011f\u0131lmas\u0131) \n– Qanaxma \n– Qolda lenf\u00f6dem (x\u00fcsusil\u0259 aksilla diseksiyas\u0131 apar\u0131ld\u0131qda) \n– D\u0259ri uyu\u015fmas\u0131 \n– Estetik v\u0259 psixoloji t\u0259sirl\u0259r<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n |